CCIA
ETNB

Campbell & Co Investment Adviser’s 89bio ETNB Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,037
Closed -$232K – 1167
2023
Q3 		$232K Buy
15,037
+2,318
+18% +$38.9K 0.03% 806
2023
Q2 		$241K Buy
+12,719
New +$223K 0.04% 746

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Campbell & Co Investment Adviser's ETNB Position: Q4 2023 in Review

Campbell & Co Investment Adviser sold out of 89bio (ETNB) in Q4 2023, closing a stake of 15,037 shares — an estimated $232K sold.

Campbell & Co Investment Adviser first reported a position in ETNB in Q2 2023 and held it in 2 quarters. The position peaked at $241K in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Campbell & Co Investment Adviser reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 15,037 89bio shares in Q4 2023, an estimated $232K.
  • Campbell & Co Investment Adviser first reported a position in 89bio in Q2 2023 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's 89bio position peaked at $241K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2023, filed 13 Feb 2024.